We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
(-5.3%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$472M |
| 2 |
EDR
Endeavor Group Holdings, Inc.
EDR
|
+$63M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$61M |
| 4 |
FYBR
Frontier Communications
FYBR
|
+$56.7M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$43.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$107M |
| 2 |
GSK
GSK
|
+$58.9M |
| 3 |
Broadcom
AVGO
|
+$54M |
| 4 |
Unilever
UL
|
+$54M |
| 5 |
Marvell Technology
MRVL
|
+$48.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.5% |
| 2 | Communication Services | 3.61% |
| 3 | Financials | 3.6% |
| 4 | Healthcare | 3.01% |
| 5 | Consumer Discretionary | 1.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
PUT
iShares Silver Trust
SLV
$28.1B
| $10.5M | 0.09% |
400,000
+194,100
| +94% | +$5.55M |
|
|
FYBR
202
CALL
DELISTED
Frontier Communications
FYBR
| $10.4M | 0.09% |
300,000
| – | – |
|
|
CHX
203
DELISTED
ChampionX
CHX
| $10.3M | 0.09% |
+380,481
| New | +$11.3M |
|
|
NVO
204
CALL
Novo Nordisk
NVO
$216B
| $10.3M | 0.09% |
120,000
-165,900
| -58% | -$17.9M |
|
205
CALL
Apple
AAPL
$4.89T
| $10.3M | 0.09% |
41,100
-194,300
| -83% | -$45.8M |
|
206
Capital One
COF
$124B
| $10.2M | 0.09% |
56,940
-3
| -0% | -$519 |
|
|
CCIRU
207
DELISTED
Cohen Circle Acquisition Corp. I Unit
CCIRU
| $10.1M | 0.09% |
+1,000,000
| New | +$10M |
|
208
CALL
Intel
INTC
$466B
| $10.1M | 0.09% |
504,400
-200,000
| -28% | -$4.51M |
|
209
Equinix
EQIX
$107B
| $10.1M | 0.08% |
10,699
-2,085
| -16% | -$1.92M |
|
|
LPBBU
210
Launch Two Acquisition Corp Unit
LPBBU
| $10.1M | 0.08% |
+1,000,000
| New | +$10M |
|
|
GSRTU
211
DELISTED
GSR III Acquisition Corp Unit
GSRTU
| $10M | 0.08% |
+998,000
| New | +$9.98M |
|
212
CALL
Capri Holdings
CPRI
$1.77B
| $10M | 0.08% |
475,000
+263,800
| +125% | +$7.18M |
|
213
Becton Dickinson
BDX
$43.1B
| $9.99M | 0.08% |
44,013
+41,238
| +1,486% | +$9.52M |
|
|
FTW
214
Presidio Production Co
FTW
$354M
| $9.98M | 0.08% |
+1,000,000
| New | +$9.93M |
|
|
FACTU
215
FACT II Acquisition Corp Unit
FACTU
| $9.98M | 0.08% |
+1,000,000
| New | +$9.96M |
|
216
Edwards Lifesciences
EW
$47.6B
| $9.89M | 0.08% |
+133,643
| New | +$9.35M |
|
|
NVMI
217
Nova
NVMI
$13.9B
| $9.89M | 0.08% |
50,209
-25,000
| -33% | -$4.8M |
|
|
GRAF
218
Graf Global Corp
GRAF
$153M
| $9.89M | 0.08% |
+980,000
| New | +$9.84M |
|
|
219
CALL
TSMC
TSM
$2.09T
| $9.87M | 0.08% |
50,000
+43,900
| +720% | +$8.5M |
|
|
220
PUT
TSMC
TSM
$2.09T
| $9.87M | 0.08% |
50,000
+11,600
| +30% | +$2.24M |
|
|
SIMA
221
SIM Acquisition Corp I
SIMA
| $9.84M | 0.08% |
+980,000
| New | +$9.8M |
|
222
Dynatrace
DT
$12.1B
| $9.78M | 0.08% |
+180,000
| New | +$9.82M |
|
|
OPTU
223
Optimum Communications Inc
OPTU
$316M
| $9.49M | 0.08% |
3,938,533
+938,533
| +31% | +$2.34M |
|
224
Coherent
COHR
$55.2B
| $9.47M | 0.08% |
100,000
| – | – |
|
225
UnitedHealth
UNH
$382B
| $9.39M | 0.08% |
18,562
+12,475
| +205% | +$7.09M |
|
Similar funds
AS
TI
LMR Partners's Q4 2024 Portfolio in Review
As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.
Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.
- LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
- LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
- LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
- LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
- LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
- LMR Partners opened 534 new positions and closed 613 in Q4 2024.
- LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.
Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.